Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9L51
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,398
Award facts
- Contract value 100% obligated
- $40,398.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,398.30 to AmerisourceBergen Drug Corp for the supply of BIKTARVY (bictegravir/tenofovir alafenamide/emtricitabine) 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and an ultimate completion date of December 4, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive IDC vehicle that supports military and veteran healthcare systems globally. This delivery order for BIKTARVY, an antiretroviral medication, exemplifies the company's role in supplying brand-name pharmaceuticals across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers. The SPE2DX contract enables flexible procurement of a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications needed across the military healthcare enterprise, positioning AmerisourceBergen as a key participant in the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9L51?
SPE2DR26F9L51 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F9L51 worth?
The government has obligated $40,398 on SPE2DR26F9L51.
Is contract SPE2DR26F9L51 an order under another contract?
Yes. SPE2DR26F9L51 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9L51 competed?
The extent of competition for SPE2DR26F9L51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award